Safety of a Novel Weight Loss Combination Product Containing Orlistat and Acarbose.
Acarbose
/ administration & dosage
Administration, Oral
Adult
Anti-Obesity Agents
/ administration & dosage
Drug Combinations
Follow-Up Studies
Glycoside Hydrolase Inhibitors
/ administration & dosage
Humans
Male
Middle Aged
Obesity
/ blood
Orlistat
/ administration & dosage
Weight Loss
/ drug effects
fixed-dose combination
gastrointestinal tolerability
modified release
obesity treatment
weight loss product
Journal
Clinical pharmacology in drug development
ISSN: 2160-7648
Titre abrégé: Clin Pharmacol Drug Dev
Pays: United States
ID NLM: 101572899
Informations de publication
Date de publication:
10 2021
10 2021
Historique:
received:
30
11
2020
accepted:
20
01
2021
pubmed:
14
2
2021
medline:
23
2
2022
entrez:
13
2
2021
Statut:
ppublish
Résumé
The safety of a novel modified-release oral capsule with orlistat and acarbose (MR-OA) was investigated in 67 obese middle-aged White men with a body mass index of 32 to 40 kg/m
Identifiants
pubmed: 33580745
doi: 10.1002/cpdd.920
pmc: PMC8518499
doi:
Substances chimiques
Anti-Obesity Agents
0
Drug Combinations
0
Glycoside Hydrolase Inhibitors
0
Orlistat
95M8R751W8
Acarbose
T58MSI464G
Types de publication
Clinical Trial, Phase II
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1242-1247Informations de copyright
© 2021 Empros Pharma AB. Clinical Pharmacology in Drug Development published by Wiley Periodicals LLC on behalf of American College of Clinical Pharmacology.
Références
Pharm Res. 1998 Feb;15(2):233-8
pubmed: 9523309
J Clin Pharmacol. 1995 Nov;35(11):1103-8
pubmed: 8626884
AAPS J. 2012 Jun;14(2):345-51
pubmed: 22419151
Pharm Res. 1995 Mar;12(3):413-20
pubmed: 7617530
Obes Rev. 2020 Dec;21(12):e13127
pubmed: 32869512
Drugs. 2006;66(12):1625-56
pubmed: 16956313
J Nutr. 2002 Jul;132(7):1892-9
pubmed: 12097665
Expert Opin Drug Saf. 2009 Nov;8(6):727-44
pubmed: 19998527
Physiol Rev. 2017 Jan;97(1):411-463
pubmed: 28003328
Clin Drug Investig. 2013 Apr;33(4):263-74
pubmed: 23435929
Arzneimittelforschung. 1989 Oct;39(10):1254-60
pubmed: 2610717
Diabet Med. 2020 Apr;37(4):623-635
pubmed: 31785118
J Pharmacokinet Biopharm. 1977 Aug;5(4):291-334
pubmed: 330836
Obes Sci Pract. 2020 Feb 07;6(3):313-323
pubmed: 32523721
Obes Rev. 2020 Oct;21(10):e13049
pubmed: 32476278
Diabetes Obes Metab. 2016 Jun;18(6):558-70
pubmed: 26936802
Clin Neuropharmacol. 2010 Jul;33(4):181-5
pubmed: 20661024